Last updated on April 20, 2014 at 5:20 EDT

Latest Imre Kovesdi Stories

2012-10-23 07:28:41

HOUSTON, Oct. 23, 2012 /PRNewswire/ -- DNAtrix, Inc., the Houston-based biotechnology company developing targeted adenovirus-based oncolytic virus products for brain cancer, announced today a merger with VectorLogics, Inc. (VLI), a company with a complementary intellectual property portfolio developing products for ovarian cancer. The merged company will retain the name DNAtrix and continue to develop its lead cancer product, DNX-2401, which is in clinical testing at the University of Texas...